RPRD Diagnostics, Children's Minnesota Collaborate
RPRD Diagnostics has announced a collaboration with Children's Minnesota dedicated to implementing a pharmacogenomic testing process. RPRD Diagnostics is a privately-held precision medicine company specializing in comprehensive pharmacogenomics (PGx) testing and analysis. RPRD aims to advance clinical pharmacogenomic testing. By implementing this process the aim is to ensure patients get the right medication at the right time, making care more precise and more affordable.
"Comprehensive pre-emptive pharmacogenomic testing is the cornerstone of precision medicine, especially in pediatrics, and RPRD Diagnostics is a pioneer in this area," said Nancy Mendelsohn, MD, senior medical director of specialty care at Children's Minnesota. "Collaborating with RPRD Diagnostics underscores our commitment to integrating pharmacogenomic medicine into the care of our patients, with the goal of providing better care and better outcomes."
Through this new collaboration, Children's Minnesota will begin using the RPRD Diagnostic platform within the cancer and blood disorder clinic as well as within the neurology-psychology practice. Clinical specialists at the Children's Minnesota genomic medicine program will work closely with RPRD Diagnostics in the implementation of this innovative service.
"We are a science-driven company focused on innovation, and we are excited to work together with Children's Minnesota," said Ulrich Broeckel, MD, founder and CEO of RPRD Diagnostics. "They have made substantial commitments toward implementing pharmacogenomics for their patients and are leading the way as a premiere pediatric healthcare provider. Historically, the application of pharmacogenetics has been limited by the high cost and limited scope of available tests—two barriers that RPRD Diagnostics has overcome. We appreciate that Children's Minnesota sees the value in our comprehensive test panels."
First Ever Online Event Focused on Cannabis ScienceNews
Analytical Cannabis is pleased to announce that the final line-up of speakers for the first ever cannabis science online event, The Science of Cannabis 2017 has been confirmed.READ MORE
New Software Allows Mobile Monitoring of Breathing ProblemsNews
Researchers have developed new software that makes it possible to use low-cost, thermal cameras attached to mobile phones to track how fast a person is breathing.READ MORE
Agilent Announces Expanded Use of Cancer Diagnostic in the USNews
Agilent announced that the FDA has approved the cancer diagnostic known as PD-L1 IHC 28-8 pharmDx for use in cases of urothelial carcinoma (UC) and of squamous cell carcinoma of the head and neck (SCCHN).READ MORE
Comments | 0 ADD COMMENT
13th Edition of International Conference on Pediatric Gastroenterology
Aug 02 - Aug 04, 2018